• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在抗反义寡核苷酸(ASO)处理的小鼠体内的肝甘油三酯分泌率。

In Vivo Hepatic Triglyceride Secretion Rate in Antisense Oligonucleotide (ASO)-Treated Mice.

机构信息

Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain.

Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.

出版信息

Methods Mol Biol. 2023;2675:15-26. doi: 10.1007/978-1-0716-3247-5_2.

DOI:10.1007/978-1-0716-3247-5_2
PMID:37258752
Abstract

The liver is a central organ in regulating the whole body metabolic homeostasis, and, among many other processes, it plays a crucial role in lipoprotein metabolism. The liver controls the secretion of very-low-density lipoproteins (VLDLs), particles specialized in the transport of liver lipids, mainly triglycerides (TGs), to the adipose tissue, heart, and muscle, among other tissues, providing fatty acids to be stored or to be used as an energy source. The analysis of this metabolic process provides relevant information about the crosstalk between the liver and other organs. It also helps to identify how the liver is able to secrete lipids to reduce its accumulation. This protocol shows how to analyze the liver TG secretion rate blocking the VLDL clearance from the blood by the administration of poloxamer 407. In addition, it shows how to isolate the VLDL produced by the liver at the end of the experiment, so that the apolipoprotein and lipid content and size can be measured. Using antisense oligonucleotides (ASOs) for silencing target proteins involved in metabolic diseases has emerged as a new promising therapeutic approach. Thus, the usage of ASOs has also been included in this protocol. As a conclusion, evaluation of TG secretion rate in mice provides key information to understand the organ crosstalk in metabolic diseases and the capacity of the liver to secrete lipids to blood.

摘要

肝脏是调节全身代谢稳态的中心器官,在许多其他过程中,它在脂蛋白代谢中起着至关重要的作用。肝脏控制极低密度脂蛋白(VLDLs)的分泌,VLDL 专门用于将肝脏脂质,主要是甘油三酯(TGs),运输到脂肪组织、心脏和肌肉等组织,为储存或用作能量来源提供脂肪酸。对这种代谢过程的分析提供了关于肝脏和其他器官之间串扰的相关信息。它还有助于确定肝脏如何能够分泌脂质以减少其积累。本方案展示了如何通过施用泊洛沙姆 407 来阻止 VLDL 从血液中清除,从而分析肝脏 TG 分泌率。此外,它还展示了如何在实验结束时分离肝脏产生的 VLDL,以便测量载脂蛋白和脂质的含量和大小。使用反义寡核苷酸(ASOs)沉默代谢疾病相关靶蛋白已成为一种新的有前途的治疗方法。因此,本方案中也包括了 ASOs 的使用。总之,评估小鼠的 TG 分泌率提供了关键信息,可帮助理解代谢疾病中的器官串扰以及肝脏向血液分泌脂质的能力。

相似文献

1
In Vivo Hepatic Triglyceride Secretion Rate in Antisense Oligonucleotide (ASO)-Treated Mice.在抗反义寡核苷酸(ASO)处理的小鼠体内的肝甘油三酯分泌率。
Methods Mol Biol. 2023;2675:15-26. doi: 10.1007/978-1-0716-3247-5_2.
2
Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice.阻断极低密度脂蛋白(VLDL)的分泌会导致小鼠肝脏脂肪变性,但不影响外周脂质储存或胰岛素敏感性。
J Lipid Res. 2008 Sep;49(9):2038-44. doi: 10.1194/jlr.M800248-JLR200. Epub 2008 Jun 1.
3
Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression.极低密度脂蛋白组装是cAMP反应元件结合蛋白H加工和肝脏载脂蛋白A-IV表达所必需的。
J Biol Chem. 2016 Nov 4;291(45):23793-23803. doi: 10.1074/jbc.M116.749283. Epub 2016 Sep 21.
4
Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion.载脂蛋白 A-IV 在小鼠肝脏中的表达通过促进极低密度脂蛋白颗粒的扩张来增加甘油三酯的分泌并减少肝内脂质含量。
Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2501-8. doi: 10.1161/ATVBAHA.113.301948. Epub 2013 Sep 12.
5
Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease.非酒精性脂肪性肝病肥胖患者中,非诺贝特和烟酸对肝内甘油三酯含量、极低密度脂蛋白动力学和胰岛素作用的影响。
J Clin Endocrinol Metab. 2010 Jun;95(6):2727-35. doi: 10.1210/jc.2009-2622. Epub 2010 Apr 6.
6
Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice.蛋氨酸腺苷转移酶 1A 基因缺失破坏了小鼠肝脏极低密度脂蛋白的组装。
Hepatology. 2011 Dec;54(6):1975-86. doi: 10.1002/hep.24607.
7
Effects of antisense-mediated inhibition of 11β-hydroxysteroid dehydrogenase type 1 on hepatic lipid metabolism.反义寡核苷酸介导的 11β-羟类固醇脱氢酶 1 抑制对肝脂代谢的影响。
J Lipid Res. 2011 May;52(5):971-81. doi: 10.1194/jlr.M013748. Epub 2011 Mar 1.
8
S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.S-腺苷甲硫氨酸可提高非酒精性脂肪性肝病患者循环中极低密度脂蛋白的清除率。
J Hepatol. 2015 Mar;62(3):673-81. doi: 10.1016/j.jhep.2014.10.019. Epub 2014 Oct 18.
9
Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.非酒精性脂肪性肝病肥胖男性和女性的脂肪组织及肝脏脂质动力学改变
Gastroenterology. 2008 Feb;134(2):424-31. doi: 10.1053/j.gastro.2007.11.038. Epub 2007 Nov 28.
10
Perilipin 5 promotes hepatic steatosis in dairy cows through increasing lipid synthesis and decreasing very low density lipoprotein assembly. perilipin 5 通过增加脂质合成和减少极低密度脂蛋白组装促进奶牛脂肪肝的形成。
J Dairy Sci. 2019 Jan;102(1):833-845. doi: 10.3168/jds.2018-15208. Epub 2018 Nov 8.

本文引用的文献

1
Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis.甲硫氨酸腺苷转移酶 1a 反义寡核苷酸激活肝脏-棕色脂肪组织轴,预防肥胖症和相关的肝脂肪变性。
Nat Commun. 2022 Mar 1;13(1):1096. doi: 10.1038/s41467-022-28749-z.
2
Metabolic-associated fatty liver disease and lipoprotein metabolism.代谢相关性脂肪性肝病与脂蛋白代谢。
Mol Metab. 2021 Aug;50:101238. doi: 10.1016/j.molmet.2021.101238. Epub 2021 Apr 20.
3
Mechanisms of NAFLD development and therapeutic strategies.
非酒精性脂肪性肝病发病机制及治疗策略。
Nat Med. 2018 Jul;24(7):908-922. doi: 10.1038/s41591-018-0104-9. Epub 2018 Jul 2.
4
Aggregation and fusion of low-density lipoproteins in vivo and in vitro.低密度脂蛋白在体内和体外的聚集与融合。
Biomol Concepts. 2013 Oct;4(5):501-18. doi: 10.1515/bmc-2013-0016.
5
Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis.过剩的 S-腺苷甲硫氨酸将磷脂酰乙醇胺重新导向磷脂酰胆碱和甘油三酯的合成。
Hepatology. 2013 Oct;58(4):1296-305. doi: 10.1002/hep.26399. Epub 2013 Aug 14.
6
Pathophysiology of human visceral obesity: an update.人类内脏肥胖的病理生理学:更新。
Physiol Rev. 2013 Jan;93(1):359-404. doi: 10.1152/physrev.00033.2011.
7
Intracellular trafficking and secretion of VLDL.VLDL 的细胞内运输和分泌。
Arterioscler Thromb Vasc Biol. 2012 May;32(5):1079-86. doi: 10.1161/ATVBAHA.111.241471.
8
The interaction of hepatic lipid and glucose metabolism in liver diseases.肝脏疾病中肝脂和糖代谢的相互作用。
J Hepatol. 2012 Apr;56(4):952-64. doi: 10.1016/j.jhep.2011.08.025. Epub 2011 Dec 13.
9
Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice.蛋氨酸腺苷转移酶 1A 基因缺失破坏了小鼠肝脏极低密度脂蛋白的组装。
Hepatology. 2011 Dec;54(6):1975-86. doi: 10.1002/hep.24607.
10
Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.乳糜微粒和 VLDL 衍生的脂质通过不同途径进入心脏:体内脂肪酸摄取的受体和非受体介导的证据。
J Biol Chem. 2010 Dec 3;285(49):37976-86. doi: 10.1074/jbc.M110.174458. Epub 2010 Sep 18.